Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China (Q45202354)

10 December 2017

title

Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China (English)

1 reference

10 December 2017

6

Umesh D Parashar

1 reference

10 December 2017

4

Jacqueline E Tate

1 reference

10 December 2017

5

Baoming Jiang

1 reference

10 December 2017

2

Catherine Yen

1 reference

10 December 2017

Na Liu

1

1 reference

10 December 2017

Zhao-yin Fang

series ordinal

3

1 reference

10 December 2017

Guang Zeng

series ordinal

7

1 reference

10 December 2017

Zhao-jun Duan

series ordinal

8

1 reference

10 December 2017

language of work or name

English

0 references

publication date

15 June 2012

1 reference

10 December 2017

1 reference

10 December 2017

volume

30

1 reference

10 December 2017

issue

48

1 reference

10 December 2017

page(s)

6940-6945

1 reference

Global Illness and Deaths Caused by Rotavirus Disease in Children

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Rotavirus and severe childhood diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Hospital-based study of the economic burden associated with rotavirus diarrhea in eastern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Econometric estimation of country-specific hospital costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Importance and challenges of accurately counting rotavirus deaths in China, 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Effectiveness of Lanzhou lamb rotavirus vaccine against hospitalized gastroenteritis: further analysis and update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

The epidemiology and burden of rotavirus in China: a review of the literature from 1983 to 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.084

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.05.084

1 reference

10 December 2017

1 reference